Oxazolidinone compounds and their use as metabotropic...

Details Oxazolidinone compounds and their use as metabotropic... Oxazolidinone compounds and their use as metabotropic...

2006-12-06

2010-10-19

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S236800, C514S376000, C514S253100, C514S254020, C514S274000, C514S340000, C544S124000, C544S138000, C544S316000, C544S364000, C544S369000, C546S271100, C548S229000

Reexamination Certificate

active

07816354

ABSTRACT:
The present invention is directed to compounds of Formula I:Wherein R1, R2, Y, m and n are further defined in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.

REFERENCES:
patent: 4186126 (1980-01-01), Messick
patent: 5106867 (1992-04-01), Bloom et al.
patent: 5410081 (1995-04-01), Konde et al.
patent: 5420291 (1995-05-01), Cain et al.
patent: 5461163 (1995-10-01), Bellon et al.
patent: 5482971 (1996-01-01), Epstein et al.
patent: 5491134 (1996-02-01), Sher et al.
patent: 5574030 (1996-11-01), Masaki et al.
patent: 5663360 (1997-09-01), Bortolaso et al.
patent: 5688785 (1997-11-01), Vaccaro
patent: 5965607 (1999-10-01), Venkatesan
patent: 6117895 (2000-09-01), Wachtel et al.
patent: 2004/0220244 (2004-11-01), Takagi et al.
patent: 2005/0197361 (2005-09-01), Jirgensons
patent: 2006/0040999 (2006-02-01), Ali et al.
patent: 153 682 (1982-01-01), None
patent: 0 294 995 (1988-12-01), None
patent: 0 455 006 (1991-11-01), None
patent: 0 579 169 (1994-01-01), None
patent: 0 657 439 (1995-06-01), None
patent: 0 659 737 (1995-06-01), None
patent: 1 236 723 (2002-09-01), None
patent: 1 435 353 (2004-07-01), None
patent: 9-268171 (1997-10-01), None
patent: 10-036359 (1998-02-01), None
patent: 11-035534 (1999-02-01), None
patent: WO-86/02268 (1986-04-01), None
patent: WO-95/28926 (1995-11-01), None
patent: WO-98/29405 (1998-07-01), None
patent: WO-99/59586 (1999-11-01), None
patent: WO-00/40560 (2000-07-01), None
patent: WO-02/094770 (2002-11-01), None
patent: WO-2004-056814 (2004-07-01), None
patent: WO-2006-014357 (2006-02-01), None
patent: WO 2006014357 (2006-02-01), None
patent: WO-2006/090792 (2006-08-01), None
Schoepp et al., Trends Pharmacol. Sci. 14:13 (1993).
Schoepp, Neurochem. Int. 24:439 (1994).
Pin et al., Neuropharmacology 34:1 (1995).
Bordi and Ugolini, Pro. Neurobiol. 59:55 (1999).
Nakanishi, Neuron 13:1031 (1994).
Knopfel et al., J. Med. Chem. 38:1417 (1995).
Bashir et al., Nature 363:347 (1993).
Bortolotto et al., Nature 368:740 (1994).
Aiba et al., Cell 79:365 (1994).
Aiba et al., Cell 79:377 (1994).
Meller et al., Neuroreport 4:879 (1993).
Bordi and Ugolini, Brainb Res. 871:223 (2000).
Pin et al., Eur. J. Pharmacol. vol. 375, p. 277-294 (1999).
Monge et al., J. Heterocyclic Chem., vol. 32, p. 1429 (1995).
Mieczkowski, Bulletin of the Polish Academy of Sciences, vol. 34, p. 109 (1986).
Das, Synthetic Communications, vol. 18, p. 907 (1988).
Tiecco et al., Chemistry—a European Journal, vol. 10, p. 1752 (2004).
Sugiyama et al., Heterocycles, vol. 57, p. 637 (2002).
Hancock et al., Tetrahedron Letters, vol. 44, p. 5457 (2003).
Hancock et al., Synthesis, vol. 14, p. 2347 (2004).
Dow et al.; Bioorganic & Medicinal Chemistry Letters, 14:12, p. 3235-3240, 2004; XP002434583.
Tiecco et al., Chemistry—A European Journal, 10:7, pp. 1752-1764, 2004, XP002434582.
Hancock et al., Tetrahedron Letters, 44:29, pp. 5457-5460, 2003, XP002434584.
Sugiyama et al., Heterocycles, 57:4, pp. 637-648, 2002, XP002434585.
Sher et al., Bioorganic & Medicinal Chemistry Letters, 7:12, pp. 1583-1588, 1997, XP002434586.
Monge et al., Journal of Heterocyclic Chemistry, 32:5, pp. 1429-1439, 1995, XP 002434587.
Bloom et al., Journal of Medicinal Chemistry, 35:16, pp. 3081-3084, 1992, XP002434588.
Das, Synthetic Communications, 18:9, pp. 907-915, 1988, XP002434589.
Mieczkowski, Bulletin of the Polish Academy of Sciences, Chemistry, 34:3-4, pp. 109-113, 1987, XP002434590.
Tsuge et al., Nippon Kagaku Zasshi, 90:10, pp. 1031-1035, 1970, XP002434591.
Burkhardt et al., Chemische Berichte, 99:6, pp. 1912-1917, 1966, XP002434592.
Gulbins et al., Chemische Berichte, 93, pp. 1975-1982, 1961, XP002434593.
Hara et al., Meijo Daigaku Sogo Kenkyusho Kiyo, 11, pp. 147-150, 2006, XP002434596.
Wrobel et al., Polish Journal of Chemistry, 80:6, pp. 907-912, 2006, XP002434597.
Siriwardana et al., Heterocycles, 66, pp. 333-339, 2006, XP002434598.

Affiliated with

Also associated with

Rating

Oxazolidinone compounds and their use as metabotropic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxazolidinone compounds and their use as metabotropic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidinone compounds and their use as metabotropic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4190917